Swissmedic issues warning about falsified Ozempic pens
Bern, 7.7.2023 - The latest generation of diabetes medications (GLP-1-agonists, e.g. Ozempic) are currently being widely discussed in the media. Since alongside their actual application, their use can also result in weight loss, they are often in demand as a slimming product. This can lead to supply shortages in some cases and to these products being purchased online or from unreliable sources (including sources abroad).